SCHEMBL1843502

SCHEMBL1843502

O=C(CCc1ccc(O)cc1)c1c(O)cccc1O

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 4/20 0.76
SGMS1 Q86VZ5 4/20 0.76
SGMS2 Q8NHU3 4/20 0.76
SLC5A1 P13866 8/20 0.74
SLC5A2 P31639 7/20 0.74
CYP19A1 P11511 3/20 0.74
MAPT P10636 3/20 0.74
GAA P10253 2/20 0.74
NFKB1 P19838 2/20 0.74
NFKB2 Q00653 2/20 0.74
RELA Q04206 2/20 0.74
MEN1 O00255 2/20 0.74
ALDH1A1 P00352 2/20 0.74
KMT2A Q03164 2/20 0.74
ATM Q13315 2/20 0.74
KDM4E B2RXH2 1/20 0.74
SLC16A3 O15427 1/20 0.74
LMNA P02545 1/20 0.74
TTR P02766 1/20 0.74
ESR1 P03372 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24842064 0.87 ACHE (0.75) ACHESGMS1SGMS2SLC5A1SLC5A2
Malabaricone B SCHEMBL30291815 0.86 ACHE (1.00) ACHESGMS1SGMS2SLC5A1SLC5A2
Phloretin SCHEMBL21192491 0.86 SLC5A1 (0.87) ACHESGMS1SGMS2SLC5A1SLC5A2
Phloretin SCHEMBL38131 0.85 SLC5A1 (1.00) ACHESGMS1SGMS2SLC5A1SLC5A2
Phloretin SCHEMBL1506325 0.85 SLC5A1 (1.00) ACHESGMS1SGMS2SLC5A1SLC5A2
SCHEMBL6397026 0.85 ACHE (0.57) ACHESGMS1SGMS2SLC5A1SLC5A2
Phloretin SCHEMBL31684375 0.84 SLC5A1 (0.96) ACHESGMS1SGMS2SLC5A1SLC5A2
Phloretin SCHEMBL30912872 0.84 SLC5A1 (0.96) ACHESGMS1SGMS2SLC5A1SLC5A2
Phloretin SCHEMBL30785809 0.84 SLC5A1 (0.96) ACHESGMS1SGMS2SLC5A1SLC5A2
SCHEMBL8115827 0.83 NFKB1 (0.77) ACHESGMS1SGMS2SLC5A1SLC5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1972203-B1 Use of 4-hydroxychalkon derivatives for masking an unpleasant taste SYMRISE AG (DE) 2012-05-16 EP claimed
EP-1977655-B1 Aroma compositions of alkamides with hesperetin and/or 4-hydroxydihydrochalkones and their salts for reinforcing sweet sensory impressions SYMRISE AG (DE) 2011-05-18 EP claimed
US-20100233102-A1 USE OF 4-HYDROXYDIHYDROCHALCONES AND THEIR SALTS FOR ENHANCING AN IMPRESSION OF SWEETNESS SYMRISE GMBH & CO. KG (DE) 2010-09-16 US claimed
EP-1998636-B1 USE OF 4-HYDROXYDIHYDROCHALCONES AND THEIR SALTS FOR ENHANCING AN IMPRESSION OF SWEETNESS SYMRISE GMBH & CO KG (DE) 2010-05-19 EP claimed
EP-1998636-A1 USE OF 4-HYDROXYDIHYDROCHALCONES AND THEIR SALTS FOR ENHANCING AN IMPRESSION OF SWEETNESS Symrise GmbH & Co. KG (DE) 2008-12-10 EP claimed
EP-1977655-A1 Aroma compositions of alkamides with hesperetin and/or 4-hydroxydihydrochalkones and their salts for reinforcing sweet sensory impressions Symrise GmbH & Co. KG (DE) 2008-10-08 EP claimed
US-20080242740-A1 AROMA COMPOSITIONS OF ALKAMIDES WITH HESPERETIN AND/OR 4-HYDROXYDIHYDROCHALCONES AND SALTS THEREOF FOR ENHANCING SWEET SENSORY IMPRESSIONS SYMRISE GMBH & CO. KG (DE) 2008-10-02 US claimed
EP-1972203-A1 Use of 4-hydroxychalkon derivatives for masking an unpleasant taste Symrise GmbH & Co. KG (DE) 2008-09-24 EP claimed
US-20080227867-A1 USE OF 4-HYDROXYCHALCONE DERIVATIVES FOR MASKING AN UPLEASANT TASTE SYMRISE GMBH & CO. KG (DE) 2008-09-18 US claimed
WO-2007107596-A1 USE OF 4-HYDROXYDIHYDROCHALCONES AND THEIR SALTS FOR ENHANCING AN IMPRESSION OF SWEETNESS SYMRISE GMBH & CO. KG (DE) 2007-09-27 WO claimed
US-20260114475-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME MARS, INCORPORATED (US) 2026-04-30 US disclosed
EP-4593631-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME Mars, Incorporated (US) 2025-08-06 EP disclosed
CN-119968127-A Animal food compositions with improved palatability and customizable properties and methods of making the same 玛氏公司 2025-05-09 CN disclosed
US-20250084049-A1 POLYCATIONIC SALTS OF PHENOLIC COMPOUNDS AND USES THEREOF FIRMENICH INCORPORATED (US) 2025-03-13 US disclosed
WO-2024073025-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME MARS, INCORPORATED (US) 2024-04-04 WO disclosed
US-20080227867-A1 USE OF 4-HYDROXYCHALCONE DERIVATIVES FOR MASKING AN UPLEASANT TASTE SYMRISE GMBH & CO. KG (DE) 2008-09-18 US disclosed
US-20080227867-A1 USE OF 4-HYDROXYCHALCONE DERIVATIVES FOR MASKING AN UPLEASANT TASTE SYMRISE GMBH & CO. KG (DE) 2008-09-18 US disclosed
WO-2007107596-A1 USE OF 4-HYDROXYDIHYDROCHALCONES AND THEIR SALTS FOR ENHANCING AN IMPRESSION OF SWEETNESS SYMRISE GMBH & CO. KG (DE) 2007-09-27 WO disclosed
WO-2007107596-A1 USE OF 4-HYDROXYDIHYDROCHALCONES AND THEIR SALTS FOR ENHANCING AN IMPRESSION OF SWEETNESS SYMRISE GMBH & CO. KG (DE) 2007-09-27 WO disclosed
US-5731292-A ANTIDIABETIC AGENTS TANABE SEIYAKU CO., LTD. (JP) 1998-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250084049-A1 POLYCATIONIC SALTS OF PHENOLIC COMPOUNDS AND USES THEREOF PGC, SLC5A6, PUF60 ACHE 4358/4885SGMS1 927/4885SGMS2 691/4885
US-20080227867-A1 USE OF 4-HYDROXYCHALCONE DERIVATIVES FOR MASKING AN UPLEASANT TASTE TAS2R45, TAS2R43, TAS2R30 ACHE 79/4885SGMS1 373/4885SGMS2 458/4885
US-20080242740-A1 AROMA COMPOSITIONS OF ALKAMIDES WITH HESPERETIN AND/OR 4-HYDROXYDIHYDROCHALCONES AND SALTS THEREOF FOR ENHANCING SWEET SENSORY IMPRESSIONS TAS2R5, TAS2R20, TAS2R40 ACHE 720/4885SGMS1 1586/4885SGMS2 1202/4885
US-20260114475-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME PIGS, TAS2R13, CEL ACHE 3373/4885SGMS1 1768/4885SGMS2 1132/4885
US-20100233102-A1 USE OF 4-HYDROXYDIHYDROCHALCONES AND THEIR SALTS FOR ENHANCING AN IMPRESSION OF SWEETNESS TAS2R4, TAS2R1, TAS2R20 ACHE 3667/4885SGMS1 777/4885SGMS2 1022/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.